2009
DOI: 10.1517/13543780903241607
|View full text |Cite
|
Sign up to set email alerts
|

Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing

Abstract: Evidence to date suggests that PDGF-BB, and to a lesser extent PDGF-AA, may have potential therapeutic use in the treatment of osteoporosis and bone healing in humans. Additionally, by targeting alpha-receptors on osteoblasts, a potential anabolic effect on bone metabolism in humans can be anticipated; however, more research needs to be done to assess the role of beta-receptors in human bone.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
57
0
2

Year Published

2010
2010
2019
2019

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 92 publications
(60 citation statements)
references
References 70 publications
1
57
0
2
Order By: Relevance
“…9 Members of this family are disulfide-bonded polypeptides that have multifunctional roles ranging from embryonic development to wound healing. [10][11][12] PDGF signaling has been implicated in several pathologic disease states 9,[13][14][15][16][17] ; however, its role in HAND, specifically as it pertains to drug abuse-related changes in barrier permeability, has not been elucidated.…”
Section: Introductionmentioning
confidence: 99%
“…9 Members of this family are disulfide-bonded polypeptides that have multifunctional roles ranging from embryonic development to wound healing. [10][11][12] PDGF signaling has been implicated in several pathologic disease states 9,[13][14][15][16][17] ; however, its role in HAND, specifically as it pertains to drug abuse-related changes in barrier permeability, has not been elucidated.…”
Section: Introductionmentioning
confidence: 99%
“…[27][28][29] A number of studies have demonstrated that in vivo administration of exogenous PDGF-BB significantly enhances bone formation. [30][31][32] Yet, in vitro studies with MSCs have reported that while exogenous PDGF-BB induces greater proliferation, it has no effect on, [33][34][35] or may even be inhibitory to, 36,37 osteogenic differentiation. With regard to ASCs, it has been shown that during osteogenic differentiation, their expression of the PDGF receptor b (PDGFR-b) is upregulated.…”
Section: Introductionmentioning
confidence: 99%
“…It has been also reported that during the early stages of wound healing PRP has a strong stimulant effect on capillary regeneration [33]. Particularly, the publications, which point out positive features of PRP over the last years, have stressed: factors (TGF-al and TGF32) for bone regeneration [51]. Our study used these principles for enhancing the osteoconductive property of a new highly purified bovine allograft (Laddec ® ) by addition of autologous PRP in regeneration of osseous defects of jaws caused by cystectomy.…”
Section: Discussionmentioning
confidence: 99%